Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anorexia Nervosa | 96 | 2023 | 1361 | 10.260 |
Why?
|
Human Growth Hormone | 38 | 2023 | 638 | 6.540 |
Why?
|
Bone Density | 70 | 2023 | 3533 | 4.270 |
Why?
|
Acromegaly | 16 | 2022 | 306 | 3.910 |
Why?
|
Body Composition | 62 | 2022 | 2416 | 3.460 |
Why?
|
Testosterone | 34 | 2023 | 2471 | 2.960 |
Why?
|
Insulin-Like Growth Factor I | 35 | 2023 | 1927 | 2.890 |
Why?
|
Hypopituitarism | 17 | 2023 | 250 | 2.710 |
Why?
|
Absorptiometry, Photon | 47 | 2023 | 1735 | 2.540 |
Why?
|
Amenorrhea | 19 | 2023 | 480 | 2.400 |
Why?
|
Overweight | 16 | 2023 | 2411 | 2.380 |
Why?
|
Androgens | 15 | 2019 | 1291 | 2.180 |
Why?
|
Obesity | 39 | 2023 | 12870 | 2.160 |
Why?
|
Hydrocortisone | 22 | 2023 | 1802 | 2.150 |
Why?
|
Premenopause | 15 | 2019 | 1038 | 2.050 |
Why?
|
Obesity, Abdominal | 6 | 2017 | 374 | 2.000 |
Why?
|
Pregnanolone | 3 | 2020 | 67 | 1.900 |
Why?
|
Hormone Replacement Therapy | 14 | 2019 | 754 | 1.870 |
Why?
|
Adipose Tissue | 26 | 2021 | 3299 | 1.740 |
Why?
|
Radius | 7 | 2023 | 440 | 1.650 |
Why?
|
Adrenal Insufficiency | 5 | 2021 | 194 | 1.370 |
Why?
|
Intra-Abdominal Fat | 11 | 2017 | 608 | 1.360 |
Why?
|
Dehydroepiandrosterone Sulfate | 6 | 2022 | 240 | 1.230 |
Why?
|
Endocrine System Diseases | 4 | 2016 | 249 | 1.220 |
Why?
|
Fasting | 7 | 2023 | 1599 | 1.200 |
Why?
|
Growth Hormone | 10 | 2023 | 568 | 1.190 |
Why?
|
Hypothalamic Diseases | 9 | 2012 | 134 | 1.190 |
Why?
|
Leptin | 20 | 2023 | 1591 | 1.190 |
Why?
|
Bone Marrow | 9 | 2021 | 2909 | 1.190 |
Why?
|
Adiposity | 11 | 2018 | 1858 | 1.180 |
Why?
|
Abdominal Fat | 3 | 2013 | 221 | 1.110 |
Why?
|
Contraceptives, Oral, Hormonal | 4 | 2019 | 190 | 1.090 |
Why?
|
Bone and Bones | 24 | 2023 | 2560 | 1.080 |
Why?
|
Peptide YY | 9 | 2015 | 136 | 1.050 |
Why?
|
Subcutaneous Fat, Abdominal | 2 | 2017 | 91 | 1.050 |
Why?
|
Oxytocin | 10 | 2023 | 401 | 1.030 |
Why?
|
Adult | 160 | 2024 | 219935 | 1.030 |
Why?
|
Body Mass Index | 44 | 2022 | 12876 | 1.000 |
Why?
|
Spine | 8 | 2023 | 1111 | 0.990 |
Why?
|
Cross-Sectional Studies | 55 | 2024 | 25956 | 0.960 |
Why?
|
Estrogens | 11 | 2022 | 1520 | 0.960 |
Why?
|
Pituitary Neoplasms | 8 | 2023 | 1313 | 0.940 |
Why?
|
Thinness | 4 | 2017 | 490 | 0.930 |
Why?
|
Bone Diseases, Metabolic | 10 | 2019 | 409 | 0.910 |
Why?
|
Pituitary Diseases | 4 | 2024 | 135 | 0.880 |
Why?
|
Estradiol | 22 | 2023 | 1933 | 0.860 |
Why?
|
Cortisone | 1 | 2023 | 87 | 0.840 |
Why?
|
Tibia | 5 | 2022 | 1065 | 0.830 |
Why?
|
Young Adult | 69 | 2024 | 58808 | 0.810 |
Why?
|
Female | 202 | 2024 | 390323 | 0.800 |
Why?
|
Bone Density Conservation Agents | 3 | 2022 | 794 | 0.780 |
Why?
|
Menstruation | 9 | 2019 | 307 | 0.770 |
Why?
|
Body Weight | 21 | 2017 | 4603 | 0.760 |
Why?
|
Adenoma | 6 | 2023 | 2148 | 0.720 |
Why?
|
Receptors, Somatotropin | 2 | 2020 | 58 | 0.700 |
Why?
|
Pelvic Bones | 2 | 2020 | 270 | 0.700 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2019 | 699 | 0.680 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 3 | 2018 | 68 | 0.680 |
Why?
|
Bone Remodeling | 6 | 2022 | 579 | 0.680 |
Why?
|
Cushing Syndrome | 3 | 2016 | 241 | 0.680 |
Why?
|
Sex Hormone-Binding Globulin | 7 | 2016 | 546 | 0.670 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.660 |
Why?
|
Humans | 232 | 2024 | 758406 | 0.660 |
Why?
|
Luteal Phase | 1 | 2019 | 138 | 0.660 |
Why?
|
Double-Blind Method | 19 | 2024 | 12262 | 0.640 |
Why?
|
Middle Aged | 96 | 2024 | 219568 | 0.630 |
Why?
|
Etidronic Acid | 2 | 2011 | 63 | 0.620 |
Why?
|
Progesterone | 2 | 2019 | 742 | 0.610 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 20 | 0.600 |
Why?
|
Growth Hormone-Releasing Hormone | 3 | 2009 | 128 | 0.600 |
Why?
|
Affective Symptoms | 2 | 2017 | 416 | 0.600 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.590 |
Why?
|
Hip | 3 | 2017 | 251 | 0.590 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2019 | 1704 | 0.570 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2018 | 415 | 0.570 |
Why?
|
Regression Analysis | 20 | 2016 | 6354 | 0.530 |
Why?
|
Depressive Disorder, Major | 5 | 2020 | 4745 | 0.510 |
Why?
|
Peptide Fragments | 9 | 2019 | 5098 | 0.510 |
Why?
|
Pituitary-Adrenal System | 2 | 2016 | 551 | 0.510 |
Why?
|
Administration, Cutaneous | 7 | 2021 | 712 | 0.500 |
Why?
|
Adolescent | 87 | 2024 | 87892 | 0.500 |
Why?
|
Somatostatin | 4 | 2020 | 447 | 0.500 |
Why?
|
Fractures, Bone | 4 | 2023 | 2040 | 0.500 |
Why?
|
Hyperprolactinemia | 5 | 2016 | 123 | 0.500 |
Why?
|
Arginine | 2 | 2009 | 933 | 0.490 |
Why?
|
Appetite | 4 | 2019 | 247 | 0.490 |
Why?
|
Yoga | 3 | 2024 | 281 | 0.480 |
Why?
|
Liver | 7 | 2024 | 7502 | 0.470 |
Why?
|
Anorexia | 1 | 2014 | 154 | 0.460 |
Why?
|
Insulin Resistance | 15 | 2020 | 3941 | 0.450 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1930 | 0.450 |
Why?
|
Anxiety | 5 | 2019 | 4539 | 0.430 |
Why?
|
Lumbar Vertebrae | 11 | 2023 | 1868 | 0.430 |
Why?
|
Diastole | 1 | 2015 | 781 | 0.430 |
Why?
|
Lipids | 6 | 2022 | 3326 | 0.430 |
Why?
|
Binge-Eating Disorder | 1 | 2015 | 147 | 0.430 |
Why?
|
Osteoporosis | 6 | 2012 | 1598 | 0.420 |
Why?
|
Glucagon | 1 | 2014 | 532 | 0.410 |
Why?
|
Reference Values | 14 | 2019 | 4919 | 0.410 |
Why?
|
Depression | 9 | 2024 | 8057 | 0.400 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2015 | 3759 | 0.400 |
Why?
|
Tomography, X-Ray Computed | 19 | 2019 | 20500 | 0.400 |
Why?
|
Menopause | 2 | 2019 | 1639 | 0.390 |
Why?
|
Male | 81 | 2024 | 358747 | 0.380 |
Why?
|
Football | 3 | 2024 | 502 | 0.380 |
Why?
|
Lipid Metabolism | 5 | 2018 | 1895 | 0.370 |
Why?
|
Anthropometry | 6 | 2018 | 1347 | 0.370 |
Why?
|
Estrogen Replacement Therapy | 6 | 2021 | 1206 | 0.370 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 597 | 0.370 |
Why?
|
Athletes | 3 | 2024 | 1125 | 0.370 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2292 | 0.370 |
Why?
|
Radioimmunoassay | 5 | 2010 | 866 | 0.360 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2016 | 1988 | 0.350 |
Why?
|
Cognition | 6 | 2016 | 6953 | 0.350 |
Why?
|
Adipocytes | 1 | 2017 | 1177 | 0.350 |
Why?
|
Antidepressive Agents | 3 | 2020 | 2889 | 0.350 |
Why?
|
Brain Concussion | 4 | 2024 | 1397 | 0.350 |
Why?
|
Finite Element Analysis | 5 | 2019 | 428 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12075 | 0.340 |
Why?
|
Cardiovascular Diseases | 14 | 2024 | 15399 | 0.330 |
Why?
|
Case-Control Studies | 30 | 2021 | 22029 | 0.330 |
Why?
|
Carrier Proteins | 2 | 2019 | 4938 | 0.320 |
Why?
|
Spinal Fractures | 1 | 2015 | 702 | 0.320 |
Why?
|
Quality of Life | 10 | 2023 | 13285 | 0.310 |
Why?
|
Triglycerides | 6 | 2010 | 2451 | 0.310 |
Why?
|
Prolactinoma | 3 | 2023 | 113 | 0.310 |
Why?
|
Gene Expression | 3 | 2021 | 7583 | 0.300 |
Why?
|
Hip Fractures | 2 | 2014 | 987 | 0.300 |
Why?
|
Placebos | 5 | 2017 | 1661 | 0.300 |
Why?
|
Pilot Projects | 9 | 2020 | 8553 | 0.300 |
Why?
|
Bone Resorption | 2 | 2011 | 720 | 0.300 |
Why?
|
Hypogonadism | 4 | 2020 | 800 | 0.290 |
Why?
|
Ghrelin | 12 | 2012 | 251 | 0.290 |
Why?
|
Adiponectin | 5 | 2010 | 1114 | 0.290 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4313 | 0.290 |
Why?
|
Diabetes Insipidus, Neurogenic | 2 | 2020 | 20 | 0.290 |
Why?
|
Weight-Bearing | 3 | 2019 | 517 | 0.280 |
Why?
|
Critical Illness | 1 | 2019 | 2703 | 0.270 |
Why?
|
Peptide Hormones | 7 | 2006 | 132 | 0.270 |
Why?
|
Depressive Disorder | 3 | 2016 | 3727 | 0.270 |
Why?
|
Erectile Dysfunction | 2 | 2020 | 451 | 0.270 |
Why?
|
Muscle, Skeletal | 6 | 2022 | 4902 | 0.270 |
Why?
|
Glucose | 7 | 2022 | 4336 | 0.260 |
Why?
|
Ergolines | 3 | 2017 | 57 | 0.260 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2009 | 540 | 0.260 |
Why?
|
Disease Management | 1 | 2016 | 2500 | 0.260 |
Why?
|
Weight Gain | 8 | 2022 | 2346 | 0.260 |
Why?
|
Sarcopenia | 2 | 2022 | 372 | 0.250 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3765 | 0.250 |
Why?
|
Drug Therapy, Combination | 4 | 2021 | 6293 | 0.240 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 392 | 0.240 |
Why?
|
Subcutaneous Fat | 3 | 2017 | 393 | 0.240 |
Why?
|
Amyloid | 1 | 2009 | 841 | 0.240 |
Why?
|
Dialysis | 1 | 2004 | 75 | 0.230 |
Why?
|
Hormones | 8 | 2015 | 869 | 0.230 |
Why?
|
Aged | 27 | 2024 | 168218 | 0.230 |
Why?
|
Growth Disorders | 1 | 2009 | 653 | 0.230 |
Why?
|
Sex Characteristics | 5 | 2018 | 2621 | 0.220 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2016 | 357 | 0.220 |
Why?
|
Bromocriptine | 1 | 2023 | 93 | 0.220 |
Why?
|
Recombinant Proteins | 6 | 2021 | 6520 | 0.220 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39059 | 0.220 |
Why?
|
Vitamin D | 4 | 2019 | 3283 | 0.210 |
Why?
|
Outpatients | 3 | 2011 | 1591 | 0.200 |
Why?
|
Gonadal Steroid Hormones | 5 | 2017 | 701 | 0.200 |
Why?
|
Femur | 4 | 2014 | 1302 | 0.200 |
Why?
|
Nutritional Status | 8 | 2005 | 1607 | 0.200 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2023 | 617 | 0.200 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1277 | 0.200 |
Why?
|
Body Fat Distribution | 2 | 2022 | 243 | 0.200 |
Why?
|
Nutrition Disorders | 1 | 2003 | 205 | 0.200 |
Why?
|
Feeding Behavior | 5 | 2019 | 3184 | 0.200 |
Why?
|
Blood Glucose | 10 | 2022 | 6346 | 0.190 |
Why?
|
Cosyntropin | 1 | 2021 | 34 | 0.190 |
Why?
|
Prevalence | 10 | 2024 | 15651 | 0.190 |
Why?
|
Exercise | 4 | 2013 | 5788 | 0.190 |
Why?
|
Osteogenesis | 3 | 2014 | 1271 | 0.190 |
Why?
|
Diabetes Insipidus | 2 | 2019 | 144 | 0.190 |
Why?
|
Treatment Outcome | 16 | 2024 | 64378 | 0.190 |
Why?
|
Thyroiditis | 1 | 2001 | 86 | 0.190 |
Why?
|
Nutrition Surveys | 3 | 2022 | 1716 | 0.190 |
Why?
|
HIV Wasting Syndrome | 2 | 1998 | 97 | 0.190 |
Why?
|
Malnutrition | 2 | 2005 | 639 | 0.190 |
Why?
|
Sports | 4 | 2009 | 699 | 0.190 |
Why?
|
Androstenedione | 1 | 2001 | 131 | 0.180 |
Why?
|
Thyrotoxicosis | 1 | 2001 | 85 | 0.180 |
Why?
|
Lithium Carbonate | 1 | 2001 | 179 | 0.180 |
Why?
|
Appetite Regulation | 2 | 2019 | 84 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 42 | 0.180 |
Why?
|
Natriuretic Peptides | 2 | 2011 | 155 | 0.180 |
Why?
|
GABA Modulators | 1 | 2020 | 109 | 0.170 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 30 | 0.170 |
Why?
|
Gyrus Cinguli | 3 | 2020 | 1115 | 0.170 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2017 | 6013 | 0.170 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.170 |
Why?
|
Ethinyl Estradiol | 3 | 2005 | 114 | 0.170 |
Why?
|
Bone Development | 2 | 2013 | 472 | 0.170 |
Why?
|
Adolescent Development | 2 | 2013 | 282 | 0.170 |
Why?
|
Abdomen | 2 | 2004 | 1129 | 0.170 |
Why?
|
Dopamine Agonists | 3 | 2014 | 352 | 0.160 |
Why?
|
Models, Biological | 1 | 2015 | 9460 | 0.160 |
Why?
|
Goserelin | 1 | 2019 | 127 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 370 | 0.160 |
Why?
|
Vasopressins | 1 | 2020 | 354 | 0.160 |
Why?
|
Calcium | 5 | 2023 | 5721 | 0.150 |
Why?
|
Contraceptive Agents, Female | 2 | 2016 | 118 | 0.150 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 161 | 0.150 |
Why?
|
Procollagen | 3 | 2014 | 187 | 0.150 |
Why?
|
Femur Neck | 1 | 2019 | 312 | 0.150 |
Why?
|
C-Reactive Protein | 7 | 2013 | 3812 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 777 | 0.150 |
Why?
|
Antimanic Agents | 1 | 2001 | 520 | 0.150 |
Why?
|
Postmenopause | 4 | 2020 | 2509 | 0.150 |
Why?
|
Contraceptives, Oral | 3 | 2011 | 554 | 0.150 |
Why?
|
Sensitivity and Specificity | 7 | 2019 | 14641 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2021 | 80168 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10748 | 0.140 |
Why?
|
Endocrinology | 2 | 2014 | 441 | 0.140 |
Why?
|
Protons | 3 | 2015 | 1112 | 0.140 |
Why?
|
HIV Protease Inhibitors | 2 | 1999 | 432 | 0.140 |
Why?
|
Lipodystrophy | 1 | 2017 | 148 | 0.140 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2016 | 49 | 0.130 |
Why?
|
Hypertension | 3 | 2024 | 8499 | 0.130 |
Why?
|
Time Factors | 8 | 2020 | 39872 | 0.130 |
Why?
|
Calcium, Dietary | 1 | 2019 | 529 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15785 | 0.130 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 296 | 0.130 |
Why?
|
Buttocks | 1 | 2016 | 111 | 0.130 |
Why?
|
Dyspareunia | 1 | 2016 | 48 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 986 | 0.130 |
Why?
|
Oxytocics | 1 | 2016 | 65 | 0.130 |
Why?
|
Administration, Oral | 4 | 2019 | 3991 | 0.130 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 141 | 0.130 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 132 | 0.130 |
Why?
|
Treatment Failure | 2 | 2019 | 2640 | 0.120 |
Why?
|
Cell Size | 1 | 2017 | 623 | 0.120 |
Why?
|
Risk Factors | 17 | 2024 | 73809 | 0.120 |
Why?
|
Cardiovascular System | 2 | 2013 | 835 | 0.120 |
Why?
|
Norgestrel | 2 | 2005 | 11 | 0.120 |
Why?
|
Vaginal Diseases | 1 | 2016 | 103 | 0.120 |
Why?
|
Lipolysis | 1 | 2016 | 209 | 0.120 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 516 | 0.120 |
Why?
|
Adipokines | 1 | 2016 | 311 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1793 | 0.120 |
Why?
|
Apolipoproteins B | 2 | 2014 | 385 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1651 | 0.120 |
Why?
|
Eating | 2 | 2019 | 1536 | 0.110 |
Why?
|
Prognosis | 8 | 2021 | 29557 | 0.110 |
Why?
|
Lipase | 1 | 2016 | 324 | 0.110 |
Why?
|
Polyuria | 1 | 2013 | 37 | 0.110 |
Why?
|
Child | 28 | 2023 | 79818 | 0.110 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 538 | 0.110 |
Why?
|
Osteocalcin | 1 | 2014 | 274 | 0.110 |
Why?
|
Hunger | 2 | 2019 | 206 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1186 | 0.110 |
Why?
|
Remission Induction | 3 | 2015 | 2388 | 0.110 |
Why?
|
Prednisone | 1 | 2017 | 1565 | 0.110 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2015 | 178 | 0.100 |
Why?
|
Hot Temperature | 1 | 2019 | 1434 | 0.100 |
Why?
|
Dehydroepiandrosterone | 2 | 2016 | 257 | 0.100 |
Why?
|
Psychopathology | 3 | 2023 | 429 | 0.100 |
Why?
|
Down-Regulation | 3 | 2021 | 2904 | 0.100 |
Why?
|
Extinction, Psychological | 1 | 2015 | 371 | 0.100 |
Why?
|
Antipsychotic Agents | 2 | 2012 | 3060 | 0.100 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 556 | 0.100 |
Why?
|
Boston | 4 | 2016 | 9304 | 0.100 |
Why?
|
Golf | 1 | 2012 | 16 | 0.100 |
Why?
|
Wrestling | 1 | 2012 | 19 | 0.100 |
Why?
|
Atrial Natriuretic Factor | 1 | 2013 | 350 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3131 | 0.100 |
Why?
|
Affect | 4 | 2013 | 1480 | 0.100 |
Why?
|
Health | 2 | 2012 | 398 | 0.100 |
Why?
|
Transdermal Patch | 1 | 2011 | 51 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2009 | 125 | 0.100 |
Why?
|
Teriparatide | 1 | 2014 | 227 | 0.100 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2011 | 25 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4839 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 5862 | 0.100 |
Why?
|
Impulsive Behavior | 1 | 2014 | 346 | 0.090 |
Why?
|
Prolactin | 3 | 2010 | 621 | 0.090 |
Why?
|
Societies, Medical | 3 | 2014 | 3891 | 0.090 |
Why?
|
Risk Assessment | 3 | 2019 | 23884 | 0.090 |
Why?
|
Comorbidity | 5 | 2021 | 10495 | 0.090 |
Why?
|
Patient Selection | 3 | 2019 | 4244 | 0.090 |
Why?
|
Calcium-Transporting ATPases | 1 | 1991 | 122 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 820 | 0.090 |
Why?
|
Prospective Studies | 11 | 2023 | 54137 | 0.090 |
Why?
|
Postprandial Period | 3 | 2019 | 314 | 0.090 |
Why?
|
Dacarbazine | 1 | 2013 | 559 | 0.090 |
Why?
|
Vagina | 1 | 2016 | 838 | 0.090 |
Why?
|
Area Under Curve | 3 | 2009 | 1632 | 0.090 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2009 | 42 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2011 | 6234 | 0.090 |
Why?
|
Personality Inventory | 2 | 2019 | 1018 | 0.090 |
Why?
|
Thyrotropin | 1 | 2013 | 832 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 346 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2013 | 617 | 0.080 |
Why?
|
Women's Health | 2 | 2016 | 2057 | 0.080 |
Why?
|
Chronic Disease | 2 | 2022 | 9267 | 0.080 |
Why?
|
Body Dysmorphic Disorders | 1 | 2013 | 243 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1377 | 0.080 |
Why?
|
Dietary Fats | 3 | 2009 | 1991 | 0.080 |
Why?
|
Mental Disorders | 3 | 2022 | 6803 | 0.080 |
Why?
|
Reproduction | 1 | 2013 | 646 | 0.080 |
Why?
|
Exercise Test | 2 | 2018 | 2121 | 0.080 |
Why?
|
Skinfold Thickness | 1 | 2008 | 158 | 0.080 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2008 | 43 | 0.080 |
Why?
|
Luteinizing Hormone | 1 | 2011 | 820 | 0.080 |
Why?
|
Interferon-beta | 1 | 2010 | 345 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2016 | 12759 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4641 | 0.080 |
Why?
|
Hip Joint | 2 | 2013 | 1006 | 0.080 |
Why?
|
Trabecular Meshwork | 1 | 2008 | 100 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2012 | 1570 | 0.080 |
Why?
|
Circadian Rhythm | 3 | 2015 | 2567 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8530 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4485 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3527 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2009 | 1125 | 0.070 |
Why?
|
United States | 6 | 2024 | 72136 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2016 | 20055 | 0.070 |
Why?
|
Body Height | 3 | 2008 | 1567 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 284 | 0.070 |
Why?
|
Sodium | 1 | 2012 | 1588 | 0.070 |
Why?
|
Running | 1 | 2012 | 483 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1374 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 841 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2009 | 890 | 0.070 |
Why?
|
Fear | 1 | 2015 | 1462 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 883 | 0.070 |
Why?
|
ROC Curve | 3 | 2011 | 3563 | 0.070 |
Why?
|
Universities | 1 | 2012 | 993 | 0.070 |
Why?
|
Age Factors | 3 | 2019 | 18358 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3801 | 0.070 |
Why?
|
Proteins | 3 | 2014 | 6026 | 0.070 |
Why?
|
Insulin | 8 | 2010 | 6578 | 0.070 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14490 | 0.070 |
Why?
|
Neurotic Disorders | 1 | 2006 | 77 | 0.070 |
Why?
|
Memory | 1 | 2016 | 2179 | 0.070 |
Why?
|
Contraceptives, Oral, Synthetic | 1 | 2005 | 16 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6201 | 0.070 |
Why?
|
Sexual Behavior | 3 | 2016 | 2158 | 0.070 |
Why?
|
Anxiety Disorders | 2 | 2016 | 2714 | 0.070 |
Why?
|
Massachusetts | 4 | 2012 | 8823 | 0.070 |
Why?
|
Bone Diseases | 1 | 2009 | 419 | 0.060 |
Why?
|
Drug Synergism | 1 | 2009 | 1745 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1845 | 0.060 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2007 | 362 | 0.060 |
Why?
|
Waist Circumference | 1 | 2008 | 921 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2010 | 849 | 0.060 |
Why?
|
Sex Factors | 3 | 2018 | 10504 | 0.060 |
Why?
|
Petrosal Sinus Sampling | 1 | 2004 | 22 | 0.060 |
Why?
|
Leg | 1 | 2010 | 1087 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 1991 | 1130 | 0.060 |
Why?
|
RNA Interference | 1 | 2013 | 2836 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2013 | 7843 | 0.060 |
Why?
|
Norethindrone | 1 | 2004 | 56 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2026 | 0.060 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2008 | 471 | 0.060 |
Why?
|
Triiodothyronine | 2 | 2005 | 493 | 0.060 |
Why?
|
Brain | 3 | 2015 | 26947 | 0.060 |
Why?
|
Fibroblast Growth Factors | 1 | 2009 | 867 | 0.060 |
Why?
|
Dietary Proteins | 1 | 2009 | 949 | 0.060 |
Why?
|
Cohort Studies | 3 | 2024 | 41256 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2008 | 1808 | 0.060 |
Why?
|
Drug Resistance | 1 | 2009 | 1593 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2044 | 0.060 |
Why?
|
Collagen Type I | 3 | 2013 | 616 | 0.050 |
Why?
|
Water | 1 | 2010 | 1402 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9273 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 437 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2008 | 15225 | 0.050 |
Why?
|
Bradycardia | 1 | 2004 | 299 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1812 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7021 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 36284 | 0.050 |
Why?
|
Lower Extremity | 1 | 2011 | 1188 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7378 | 0.050 |
Why?
|
Basal Metabolism | 2 | 2006 | 161 | 0.050 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2003 | 116 | 0.050 |
Why?
|
Fluoxetine | 1 | 2006 | 733 | 0.050 |
Why?
|
Malabsorption Syndromes | 1 | 2003 | 135 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 1998 | 4504 | 0.050 |
Why?
|
Students | 1 | 2012 | 1734 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10652 | 0.050 |
Why?
|
Space Perception | 1 | 2004 | 464 | 0.050 |
Why?
|
Nutrition Assessment | 2 | 2004 | 726 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6954 | 0.050 |
Why?
|
Menstrual Cycle | 2 | 2004 | 536 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29742 | 0.050 |
Why?
|
Self Concept | 1 | 2007 | 1041 | 0.050 |
Why?
|
Up-Regulation | 3 | 2021 | 4113 | 0.050 |
Why?
|
Deficiency Diseases | 1 | 2001 | 74 | 0.050 |
Why?
|
Libido | 1 | 2001 | 119 | 0.050 |
Why?
|
Social Behavior | 1 | 2007 | 1131 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2009 | 1184 | 0.040 |
Why?
|
Glucose Tolerance Test | 3 | 2010 | 1172 | 0.040 |
Why?
|
Arousal | 1 | 2006 | 1157 | 0.040 |
Why?
|
Mitochondria | 1 | 2013 | 3584 | 0.040 |
Why?
|
Cholesterol | 3 | 2008 | 2902 | 0.040 |
Why?
|
Graves Disease | 1 | 2001 | 238 | 0.040 |
Why?
|
Muscles | 3 | 2014 | 1579 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1433 | 0.040 |
Why?
|
Homeostasis | 1 | 2010 | 3301 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 352 | 0.040 |
Why?
|
Satiation | 1 | 2019 | 83 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 2019 | 125 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2006 | 6457 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58683 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 855 | 0.040 |
Why?
|
Aging | 2 | 2016 | 8650 | 0.040 |
Why?
|
Neoplasms | 2 | 2024 | 22032 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2010 | 3806 | 0.040 |
Why?
|
Thyroxine | 1 | 2001 | 667 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 1032 | 0.040 |
Why?
|
Ovulation | 1 | 1998 | 181 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7985 | 0.040 |
Why?
|
E-Selectin | 2 | 2010 | 576 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3783 | 0.040 |
Why?
|
Endocrine Glands | 1 | 1997 | 101 | 0.040 |
Why?
|
Pituitary Hormones | 2 | 2010 | 182 | 0.040 |
Why?
|
Emotions | 1 | 2009 | 2734 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 697 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1263 | 0.040 |
Why?
|
Pituitary Gland | 2 | 2013 | 637 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 2013 | 1066 | 0.030 |
Why?
|
Interleukin-6 | 4 | 2009 | 3208 | 0.030 |
Why?
|
Orgasm | 1 | 2016 | 61 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 1999 | 400 | 0.030 |
Why?
|
Brain Hemorrhage, Traumatic | 1 | 2015 | 18 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1542 | 0.030 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2016 | 62 | 0.030 |
Why?
|
Administration, Intravaginal | 1 | 2016 | 151 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5816 | 0.030 |
Why?
|
Lipoprotein(a) | 1 | 2000 | 479 | 0.030 |
Why?
|
Glycoproteins | 1 | 2003 | 2205 | 0.030 |
Why?
|
Inflammation | 2 | 2014 | 10718 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2010 | 3204 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13591 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5759 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 168 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11892 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 511 | 0.030 |
Why?
|
HIV Infections | 2 | 1998 | 17275 | 0.030 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3671 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2825 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2001 | 1168 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 2209 | 0.030 |
Why?
|
Avoidance Learning | 1 | 2015 | 248 | 0.030 |
Why?
|
Athletic Injuries | 1 | 2024 | 1211 | 0.030 |
Why?
|
Pituitary Gland, Posterior | 1 | 2013 | 42 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2012 | 2359 | 0.030 |
Why?
|
Thorax | 2 | 2008 | 553 | 0.030 |
Why?
|
Chemical Phenomena | 1 | 2013 | 508 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2016 | 3586 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 960 | 0.030 |
Why?
|
Calorimetry, Indirect | 2 | 2006 | 174 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2008 | 14354 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 961 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7980 | 0.030 |
Why?
|
Trace Elements | 2 | 2006 | 196 | 0.030 |
Why?
|
Puberty | 2 | 2007 | 498 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 349 | 0.030 |
Why?
|
Cyclic GMP | 1 | 2013 | 395 | 0.020 |
Why?
|
Organ Size | 2 | 2010 | 2252 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2015 | 5199 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2690 | 0.020 |
Why?
|
Schizophrenia | 1 | 2010 | 6910 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2016 | 376 | 0.020 |
Why?
|
Diet | 1 | 2009 | 8005 | 0.020 |
Why?
|
Calcium Radioisotopes | 1 | 1991 | 9 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1128 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9599 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 514 | 0.020 |
Why?
|
Incidence | 2 | 2024 | 21272 | 0.020 |
Why?
|
Sodium Chloride, Dietary | 1 | 2013 | 293 | 0.020 |
Why?
|
Psychometrics | 2 | 2014 | 3052 | 0.020 |
Why?
|
Extremities | 2 | 2008 | 865 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1530 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2015 | 665 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2197 | 0.020 |
Why?
|
Hyponatremia | 1 | 2012 | 279 | 0.020 |
Why?
|
Menarche | 2 | 2004 | 529 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2015 | 814 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3432 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1991 | 700 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1241 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2010 | 288 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2090 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 815 | 0.020 |
Why?
|
Energy Intake | 3 | 2006 | 2127 | 0.020 |
Why?
|
Mental Recall | 1 | 2015 | 1208 | 0.020 |
Why?
|
Satiety Response | 1 | 2009 | 47 | 0.020 |
Why?
|
Peptides | 2 | 2013 | 4341 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1304 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1991 | 1543 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 8945 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 108 | 0.020 |
Why?
|
Astrocytoma | 1 | 2013 | 775 | 0.020 |
Why?
|
Fats | 1 | 2009 | 99 | 0.020 |
Why?
|
Acylation | 1 | 2008 | 97 | 0.020 |
Why?
|
Risperidone | 1 | 2010 | 379 | 0.020 |
Why?
|
Sexual Development | 1 | 2008 | 40 | 0.020 |
Why?
|
Disabled Persons | 1 | 2018 | 1224 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2005 | 2697 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.020 |
Why?
|
Amygdala | 1 | 2015 | 1350 | 0.020 |
Why?
|
Thyroid Hormones | 1 | 2010 | 403 | 0.020 |
Why?
|
Echocardiography | 2 | 2010 | 4962 | 0.020 |
Why?
|
Gonadotropins | 1 | 2008 | 241 | 0.020 |
Why?
|
Growth Plate | 1 | 2008 | 274 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3612 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2013 | 8981 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1187 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2608 | 0.020 |
Why?
|
Body Image | 1 | 2010 | 637 | 0.020 |
Why?
|
Growth | 1 | 2007 | 365 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2016 | 2055 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4071 | 0.020 |
Why?
|
Diet Records | 1 | 2006 | 427 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8175 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1386 | 0.010 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.010 |
Why?
|
Ovary | 1 | 2009 | 958 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13468 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2006 | 622 | 0.010 |
Why?
|
Age Determination by Skeleton | 1 | 2004 | 126 | 0.010 |
Why?
|
Hematocrit | 1 | 2005 | 627 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2007 | 640 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2006 | 373 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2005 | 320 | 0.010 |
Why?
|
Steroids | 1 | 2009 | 926 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 238 | 0.010 |
Why?
|
Periodicity | 1 | 2005 | 348 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
Animals | 3 | 2013 | 167768 | 0.010 |
Why?
|
Lipoproteins | 1 | 2008 | 881 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8426 | 0.010 |
Why?
|
Osteoprotegerin | 1 | 2003 | 176 | 0.010 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2004 | 361 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 2004 | 350 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1668 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3507 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 664 | 0.010 |
Why?
|
Seizures | 1 | 2015 | 2919 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2006 | 759 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2013 | 1634 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2850 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1088 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3714 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16534 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4711 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2895 | 0.010 |
Why?
|
Energy Metabolism | 2 | 2006 | 2868 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81101 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 584 | 0.010 |
Why?
|
Potassium | 1 | 2004 | 1310 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4048 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2006 | 1419 | 0.010 |
Why?
|
Nutritional Requirements | 1 | 2000 | 275 | 0.010 |
Why?
|
Phosphates | 1 | 2002 | 771 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 2020 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2006 | 1688 | 0.010 |
Why?
|
Vitamins | 1 | 2006 | 1632 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2006 | 2004 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5427 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2006 | 2058 | 0.010 |
Why?
|
Stroke Volume | 1 | 2010 | 5460 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23342 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11471 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29915 | 0.010 |
Why?
|
Rats | 1 | 1991 | 23679 | 0.010 |
Why?
|
Electric Impedance | 1 | 1998 | 754 | 0.010 |
Why?
|
Recovery of Function | 1 | 2004 | 2970 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15773 | 0.010 |
Why?
|
Heart Rate | 1 | 2004 | 4166 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2001 | 2374 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12096 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13961 | 0.010 |
Why?
|
Blood Pressure | 1 | 2004 | 8451 | 0.010 |
Why?
|